| 165.09 4.19 (2.6%) | 12-08 16:01 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 202.48 | 1-year : | 236.5 |
| Resists | First : | 173.36 | Second : | 202.48 |
| Pivot price | 148.07  |
|||
| Supports | First : | 142.4 | Second : | 123.26 |
| MAs | MA(5) : | 156.46 |
MA(20) : | 144.71 |
| MA(100) : | 196.11 |
MA(250) : | 241.42 |
|
| MACD | MACD : | 0.9 |
Signal : | -2.4 |
| %K %D | K(14,3) : | 86 |
D(3) : | 82.4 |
| RSI | RSI(14): 61.2 |
|||
| 52-week | High : | 330 | Low : | 123.26 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ INSP ] has closed above the upper band by 7.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 42.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 168.4 - 169.05 | 169.05 - 169.7 |
| Low: | 157.96 - 158.72 | 158.72 - 159.48 |
| Close: | 163.85 - 165.03 | 165.03 - 166.21 |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Fri, 08 Dec 2023
Is Inspire Medical Systems (INSP) a Smart Investment or a Value Trap? An In-Depth Exploration - GuruFocus.com
Fri, 08 Dec 2023
Is Inspire Medical Systems Inc (INSP) a Stock to Watch After Gaining 13.55% This Week? - InvestorsObserver
Fri, 08 Dec 2023
Ergoteles LLC Boosts Position in Inspire Medical Systems, Inc. (NYSE:INSP) - MarketBeat
Thu, 07 Dec 2023
Inspire (INSP) Up 16.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Thu, 07 Dec 2023
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Sold by BlackRock Inc. - MarketBeat
Thu, 07 Dec 2023
Should You Sell Inspire Medical Systems (INSP)? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical Devices
|
|
| Shares Out | 30 (M) |
| Shares Float | 29 (M) |
| Held by Insiders | 1.5 (%) |
| Held by Institutions | 99.8 (%) |
| Shares Short | 1,320 (K) |
| Shares Short P.Month | 1,170 (K) |
| EPS | -1.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.51 |
| Profit Margin | -5.8 % |
| Operating Margin | -8.8 % |
| Return on Assets (ttm) | -5.4 % |
| Return on Equity (ttm) | -6.5 % |
| Qtrly Rev. Growth | 40.4 % |
| Gross Profit (p.s.) | 11.57 |
| Sales Per Share | 19.31 |
| EBITDA (p.s.) | -1.61 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 27 (M) |
| Levered Free Cash Flow | 12 (M) |
| PE Ratio | -148.73 |
| PEG Ratio | -2.3 |
| Price to Book value | 8.91 |
| Price to Sales | 8.54 |
| Price to Cash Flow | 182.8 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|